country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-187554

Copy Link Print Information

IDP-73152

IDP-73152 is an orally active bacterial Peptide deformylase inhibitor and Antibiotic. IDP-73152 exhibits activity against Gram-positive bacteria. IDP-73152 can be used in the research of infections caused by Streptococcus pneumoniae, Enterococcus faecium and Staphylococcus aureus.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No.: 1091682-50-6
Formule: C₂₈H₄₁F₃N₄O₄
Masse moléculaire:554.66

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

IDP-73152 Chemical Structure

CAS No.: 1091682-50-6

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- In Vitro
- Parmacokinetics
- In Vivo
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

Voir tous les produits spécifiques à Isoform Antibiotic :

In Vitro

IDP-73152 (10 μM; 2 h) exhibits good permeability across Caco-2 cell monolayers with low efflux, as shown by P_app values of 31.2 × 10^-6 cm/s (A-to-B) and 49.5 × 10^-6 cm/s (B-to-A) and an efflux ratio <2^[3].
IDP-73152 (0.3 μM; 240 min) is unstable in rat blood, with a blood clearance of 0.0430 L/h/kg, which contributes minimally to overall systemic clearance in rats^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Parmacokinetics

Species	Dose	Route	T_max	C_max	T_1/2	MRT	AUC_0-24	AUC_0-∞
Mice^[1]	80 mg/kg	p.o.	0.50 h	8950 ng/mL	2.70 h	4.50 h	46500 ng·h/mL	46600 ng·h/mL
Rat^[1]	80 mg/kg	p.o.	0.28 h	6300 ng/mL	2.89 h	4.86 h	31500 ng·h/mL	31600 ng·h/mL

In Vivo

Bacterial Infection

IDP-73152 (p.o.; twice daily) produces 50% survival in infected mice with ED₅₀ values of 3.0 mg/kg (penicillin-resistant Streptococcus pneumoniae), 13.3 mg/kg (vancomycin-resistant Enterococcus faecium), and 16.6 mg/kg (methicillin-resistant Staphylococcus aureus)^[2].
IDP-73152 (p.o.; twice daily) exhibits in vivo antibacterial efficacy in infected mice, with ED₅₀ values for survival of 3.0 mg/kg, 13.3 mg/kg, and 16.6 mg/kg against penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus, respectively^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

unspecified strain^[2]
Dosage:

Various dosages
Administration:

p.o.; twice daily
Result:

Achieved an ED₅₀ of 3.0 mg/kg in penicillin-resistant Streptococcus pneumoniae-infected mice.
Achieved an ED₅₀ of 13.3 mg/kg in vancomycin-resistant Enterococcus faecium-infected mice.
Achieved an ED₅₀ of 16.6 mg/kg in methicillin-resistant Staphylococcus aureus-infected mice.

Related Protocols :

Gram Staining of Tissue Sections

Chemical Information

CAS No. 1091682-50-6
Masse moléculaire 554.66
Formule C₂₈H₄₁F₃N₄O₄
SMILES

[C@@H](C(N[C@H](C(=O)N1CCC(NCC2=C(F)C=C(F)C(F)=C2)CC1)C(C)(C)C)=O)(CC3CCCC3)CN(C=O)O
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Instruction de manipulation (2659 KB)

Références

[1]. Lee M, et al. Quantification of IDP-73152, a novel antibiotic, in plasma from mice, rats and humans using an ultra-high performance liquid chromatography/tandem mass spectrometry method for use in pharmacokinetic studies. Journal of pharmaceutical and biomedical analysis. 2017 Oct 25;145:364-371.

[2]. 이명재. Physiologically-based pharmacokinetic modeling of a novel antibacterial drug (IDP-73152) for prediction of its pharmacokinetics in humans[D]. 서울대학교 대학원, 2022.

[3]. Lee M, et al. Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics. Pharmaceutics. 2022 May 28;14(6):1157.

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Obtenir un devis En stock

Other size

Obtenir un devis